Medivation Inc - Strategic SWOT Analysis Review

November 2017 | 40 pages | ID: M50B5DAF3DCEN
GlobalData

Abstracts

Medivation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Medivation Inc (Medivation), a subsidiary of Pfizer is a biopharmaceutical company which develops and commercializes medically innovative therapies to treat serious diseases. The company’s product Xtandi is developed for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). The company with collaboration with Astellas conducts studies for the treatment of enzalutamide in prostate cancer, advanced breast cancer and hepatocellular carcinoma. The company offers its product to pharmaceuticals, biotechnology drugs and medical devices. It operates along with its subsidiaries in the US and in the UK. Medivation is headquartered in San Francisco, California, the US.

Medivation Inc Key Recent Developments

Aug 09,2016: Medivation Reports Second Quarter 2016 Financial Results
Jul 05,2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information
Jun 13,2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board
Jun 01,2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation’s Board of Directors
May 27,2016: Medivation Files Preliminary Consent Revocation Statement

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Medivation Inc - Key Facts
Medivation Inc - Key Employees
Medivation Inc - Key Employee Biographies
Medivation Inc - Major Products and Services
Medivation Inc - History
Medivation Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Medivation Inc - Business Description
Medivation Inc - Corporate Strategy
Medivation Inc - SWOT Analysis
SWOT Analysis - Overview
Medivation Inc - Strengths
Medivation Inc - Weaknesses
Medivation Inc - Opportunities
Medivation Inc - Threats
Medivation Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Medivation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Medivation Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Aug 09, 2016: Medivation Reports Second Quarter 2016 Financial Results
Jul 05, 2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information
Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board
Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation’s Board of Directors
May 27, 2016: Medivation Files Preliminary Consent Revocation Statement
May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation’s Board
May 05, 2016: Sanofi Sends Letter to Medivation’s Board
May 05, 2016: Medivation Reports First Quarter 2016 Financial Results
Mar 28, 2016: Jennifer Jarrett to Join Medivation as Chief Financial Officer
Feb 25, 2016: Medivation Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Financial Guidance

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Medivation Inc, Key Facts
Medivation Inc, Key Employees
Medivation Inc, Key Employee Biographies
Medivation Inc, Major Products and Services
Medivation Inc, History
Medivation Inc, Subsidiaries
Medivation Inc, Key Competitors
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Medivation Inc, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Medivation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Medivation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Tesaro Inc
Orion Corporation
Novus Therapeutics Inc
GTx Inc
Aragon Pharmaceuticals Inc